J&J | JNJ - Umlaufvermögen





Umlaufvermögen Veränderung Datum
AbbVie USD 33.53B 4.47B 2026-03
Abbott USD 25.51B 488M 2026-03
Amgen USD 31.48B 2.42B 2026-03
AstraZeneca USD 27.97B 1.65B 2026-06
Baxter International USD 6.99B 142M 2026-06
Bayer EUR 35.3B 2.39B 2026-03
Becton, Dickinson and Co. USD 8.01B 1.18B 2026-03
Biogen USD 7.31B 1.88B 2026-06
Boston Scientific USD 8.68B 110M 2026-03
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
CONMED USD 675.66M 5.07M 2026-06
Cooper Companies USD 2.3B 166M 2026-03
Dexcom USD 4.09B 245.1M 2026-06
Edwards Lifesciences USD 6.23B 510.2M 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
GlaxoSmithKline GBP 17.56B 202M 2026-06
Globus Medical USD 2.2B 72.51M 2026-03
Insulet USD 1.71B 204.5M 2026-03
Integra LifeSciences USD 1.19B 19.46M 2026-06
Intuitive Surgical USD 12.33B 807.5M 2026-06
J&J USD 59.77B 601M 2026-06
Medtronic USD 24.07B 75M 2025-12
Merck USD 35.02B 8.5B 2026-03
Merit Medical Systems USD 1.11B 10.46M 2026-06
Novartis USD 27.35B 744M 2026-06
Pfizer USD 42.82B 76M 2026-03
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Stryker USD 14.42B 1.08B 2026-06
Tandem Diabetes Care USD 887.1M 268.96M 2026-03
Teva Pharmaceutical Industries USD 13.76B 50M 2026-06
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03
Zimmer Biomet Holdings USD 4.96B 157.4M 2026-03
Zoetis USD 6.47B 294M 2026-03